Romedahl MedScience ApS: Financial statements 2023
CVR: 38540580
Source: annual report 2023, Danish Business Authority
01/01/2023 – 31/12/2023
Romedahl MedScience ApS (CVR 38540580) has filed annual accounts for 2023. In 2023, the company reported a net result of DKK -6,089 compared with DKK -4,945 the year before. Equity in the 2023 report amounted to DKK 15,592. The solvency ratio was 48.6%. The company had 1 employee in the financial year.
- Profit/Loss
- DKK -6,089
- Equity
- DKK 15,592
- Total Assets
- DKK 32,074
- Employees
- 1
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2023 | - | - | -6K | 16K | 1 |
| 2022 | - | - | -5K | 22K | 1 |
| 2021 | - | - | -8K | 27K | 1 |
| 2020 | - | - | -9K | -5K | 1 |
| 2019 | - | 0 | 0 | 4K | 0 |
Official annual report
Fetch this data via API
Every Danish company, financial statement and ownership record, straight into your own systems or your AI assistant via MCP.
See the API documentationEvents in 2023
Romedahl MedScience ApS has published its annual report for 2022. The net result was DKK -4,945.
About Romedahl MedScience ApS
Romedahl MedScience ApS is a Danish company of the type Anpartsselskab based in Roskilde, founded in 2017. The company is registered under the industry Virksomhedsrådgivning og anden ledelsesrådgivning. The company was previously named Romedahl MedScience IVS. The management consists of Hanne Risager Romedahl. The company is owned by Hanne Risager Romedahl. According to the 2025 annual report, the company had an average of 0 employees. In 2025, the company reported a net result of DKK -8,552 compared with DKK -6,398 the year before. Equity in the 2025 report amounted to DKK 642.